[1] Heo S J, Jung I, Lee C K, et al. A randomized phase Ⅱ trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer[J]. Cancer Chemotherapy Pharmacology, 2016, 77(3):539-548.
[2] Dela C C S, Tanoue L T, Matthay R A. Lung cancer:epidemiology, etiology, and prevention[J]. Clinic in Chest Medicine, 2011, 32(4):605-644.
[3] Tang S, Pan Y, Wang Y, et al. Genome-wide association study of survival in early-stage non-small cell lung cancer[J]. Annals Surgical Oncology, 2015, 22(2):630-635.
[4] Xu Y H, Lu S. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with nonsmall-cell lung cancer[J]. European Journal of Surgical Oncology, 2014, 40(3):311-317.
[5] Yang M, Cao H, Guo X, et al. The number of resected lymph nodes (nLNs) combined with tumor size as a prognostic factor in patients with pathologic N0 and Nx non-small cell lung cancer[J]. PLoS One, 2013, 8(9):e73220.
[6] Nwogu CE, Groman A, Fahey D, et al. Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer[J]. The Annals of Thoracic Surgery, 2012, 93(5):1614-1619.
[7] Ashraf H, Dirksen A, Loft A, et al. Combined use of positron emission tomography and volume doubling time in lung cancer screening with low-dose CT scanning[J]. Thorax, 2011, 66(4):315-319.
[8] Al-Kadi O S. Assessment of texture measures susceptibility to noise in conventional and contrast enhanced computed tomography lung tumour images[J]. Computerized Medical Imaging and Graphics, 2010, 34(6):494-503.
[9] Pfluger T, Melzer H I, Schneider V, et al. PET/CT in malignant melanoma:contrast-enhanced CT versus plain low-dose CT[J]. European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38(5):822-831.
[10] Lyv Y L, Yuan D M, Wang K, et al. Diagnostic performance of integrated positron emission tomography/computed tomography for mediastinal lymph node staging in non-small cell lung cancer:a bivariate systematic review and meta-analysis[J]. Journal of Thoracic Oncology, 2011, 6(8):1350-1358.
[11] Huellner M W, de Galiza Barbosa F, Husmann L, et al. TNM staging of non-small cell lung cancer:comparison of PET/MR and PET/CT[J]. Journal of Nuclear Medicine, 2016, 57(1):21-26.
[12] Baba T, Uramoto H, Kuwata T, et al. A study of surgically resected peripheral non-small cell lung cancer with a tumor diameter of 1.0 cm or less[J]. Scandinavian Journal of Surgery, 2011, 100(3):153-158.
[13] Donnem T, Hald S M, Paulsen E E, et al. Stromal CD8+ T-cell density-a promising supplement to TNM staging in non-small cell lung cancer[J]. Clinical Cancer Research, 2015, 21(11):2635-2643.
[14] Shien K, Toyooka S, Soh J, et al. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division[J]. Interactive Cardiovascular and Thoracic Surgery, 2015, 20(6):791-796.
[15] Liu X H, Liu Z L, Sun M, et al. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer[J]. BMC Cancer, 2013, 13:464.
[16] Tsutani Y, Miyata Y, Nakayama H, et al. Appropriate sublobar resection choice for ground glass opacitydominant clinical stage IA lung adenocarcinoma:wedge resection or segmentectomy[J]. Chest, 2014, 145(1):66-71.
[17] Stojiljkovic D, Santrac N, Stojiljkovic T, et al. Correlation of tumor size as independent factor and disease stage with local recurrence of non-small cell lung carcinoma and its operability[J]. Journal of BUON, 2015, 20(1):166-172.
[18] Kang S, Kim Y S, Choi H J, et al. Additional value of combined evaluation of tumor size with lymph node size in the detection of lymph node metastases in earlystage cervical cancer patients[J]. Journal of Computer Assisted Tomography, 2013, 37(4):572-576.
[19] Osarogiagbon R U, Eke R, Sareen S, et al. The impact of a novel lung gross dissection protocol on intrapulmonary lymph node retrieval from lung cancer resection specimens[J]. Annals of Diagnostic Pathology, 2014, 18(4):220-226.
[20] Agarwal M, Brahmanday G, Chmielewski G W, et al. Age, tumor size, type of surgery, and gender predict survival in early stage (stage Ⅰ and Ⅱ) non-small cell lung cancer after surgical resection[J]. Lung Cancer, 2010, 68(3):398-402.
[21] Tateishi Y, Nakanishi Y, Taniguchi H, et al. Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma[J]. Modern Pathology, 2010, 23(8):1068-1072.
[22] Dai C, Ren Y, Xie D, et al. Does lymph node metastasis have a negative prognostic impact in patients with NSCLC and M1a disease?[J].Journal of Thoracic Oncology, 2016, 11(10):1745-1754. |